Nirrin

Nirrin Technologies is a bioprocess analytics company based in Billerica, Massachusetts, founded in 2018. The company focuses on developing analytical systems for the biomanufacturing and pharmaceutical development sectors, aiming to enhance the manufacturing of biologics and advanced therapies.

Nirrin's flagship product, the Atlas™ system, utilizes High-Precision Tunable Laser Spectroscopy (HPTLS) technology. This near-infrared spectroscopy platform offers real-time, quantitative analysis of bioprocesses, delivering results significantly faster and more efficiently than traditional methods. The Atlas system supports at-line, in-line, and in-situ analysis, providing critical insights into product titer and buffer/excipient concentrations. Nirrin also holds 13 patents, with innovations in bioreactors, biotechnology, and spectroscopy.

The company serves the pharmaceutical development sector and manufacturers of complex biologics, helping them optimize bioprocess workflows, reduce development costs, and improve process control. Nirrin Technologies has been recognized for its contributions, being selected for the 2025 BioTools Innovator Accelerator program and raising over $15 million in funding.